Stockreport

Israel Patent Office Grants New Patent Covering Enlivex’s Allocetra Immunotherapy Treatment

Enlivex Therapeutics Ltd. - Ordinary Shares  (ENLV) 
PDF Nes-Ziona, March 09, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics, Ltd., a clinical-stage immunotherapy company, today announced that the Israel Patent Office granted [Read more]